IGF1R and breast cancer: Results of this NHS2 study of predominantly White (> 90%) women demonstrate a 33% lower risk of developing HR+ breast cancer in those with a self-reported history of preeclampsia who also inherited the protective IGF1R T allele of rs2016347.